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Abstract 
The binding of coomassie brilliant blue G (CBB) to bovine serum albumin (BSA) 
was investigated under simulative physiological conditions employing different 
optical spectroscopic techniques viz., fluorescence emission, UV–visible 
absorption and FTIR. Fluorescence quenching data obtained at different 
temperatures suggested the presence of dynamic type of quenching 
mechanism. The binding constant of CBB-BSA and the number of binding sites 
(n) for CBB in BSA were calculated and found to be 4.20 x 10
4 M
−1 and 0.96 
respectively, at 302 K. The value of n close to unity indicated that the protein 
has a single class of binding sites for CBB. The thermodynamic parameters 
revealed that the hydrophobic forces played a major role in the interaction of 
CBB to BSA. The distance between the CBB and protein was calculated using 
the theory of Föster’s Resonance Energy Transfer (FRET). The conformational 
change in the secondary structure of BSA upon interaction with dye was 
investigated by synchronous fluorescence and FTIR techniques. Competitive 
binding studies were also carried out to know the location of binding of CBB on 
BSA.  
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Introduction 
Coomassie brilliant blue G (CBB) dye (Fig. 1), [also known as coomassie dye] is employed 
to stain proteins in sodium dodecyl sulfate and blue native polyacrylamide gel in 
electrophorosis gels. It is used in the quantification of electrophoretically separated protein 
[1]. The CBB has also been popularly used in biochemical and clinical laboratories for the 
purification and quantification of proteins [2]. Recently, CBB was used in the treatment of 
spinal injuries in rats [3]. It was also used as a stain to assist surgeons in retinal surgery 
[4]. 
Serum albumin (SA), often simply referred as albumin, is the most abundant plasma 
protein in humans as well as in other mammals which plays a major role in the transport 
and deposition of many drugs in the blood. This albumin is essential for the maintenance 
of osmotic pressure which is needed for proper distribution of body fluids between 
intravascular components and body tissues. SA consists of three homologous domains  
(I–III), each of them is composed of two subdomains (A and B) [5, 6]. In the IIA and IIIA 
pocket, the majority of small ligands like drugs are bound and carried to the target site  
[7–10]. Therefore, it is important to study the interaction of the drug with the serum 
albumin, which plays an important role in pharmacology, pharmacokinetics and pharmaco-
dynamics. In this regard, bovine serum albumin (BSA) has been studied extensively, partly 
because of its structural homology with human serum albumin (HSA) [11]. 
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Fig. 1.  Structure of Coomassie brilliant blue G. 
In the present report, we have focused on the interaction of CBB with bovine serum 
albumin and obtained the information with regard to binding constant, number of binding 
sites, thermodynamic parameters, and conformational changes in the protein employing 
spectroscopic techniques. Among these, fluorescence technique is a well known practical 
method for studying protein interactions with various ligands [12–14] as it yields a vast 
amount of information on binding characteristics and the microenvironment surrounding 
the protein residues.  
Materials and Methods 
Materials 
Bovine serum albumin (fatty acid free, fraction V) and Brilliant blue G–250 were purchased 
from Sigma Chemicals Co. Millipore water was used throughout the experiment. All other 
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Equipment and spectral measurements 
The fluorescence spectra were recorded on a spectrofluorimeter model F–7000 (Hitachi, 
Japan) equipped with a 1.0 cm quartz cell and a thermostat bath. Inner filter effect was not 
observed during fluorescence measurements. Necessary corrections have been made. 
The widths of both excitation and emission slit were set to 5 nm in the experiment. The 
UV–vis spectra were recorded on a double beam CARY 50–BIO UV–vis spectro-
photometer (Varian, Australia) equipped with a 1.0 cm quartz cell and a slit width of 5 nm. 
FTIR spectra were acquired on a Thermo Nicolet–5700 FTIR spectrometer (Waltham, MA, 
USA). 
Procedures 
The fluorimetric titrations were carried out and the fluorescence intensities of protein were 
recorded at around 340 nm upon excitation at 296 nm. Based on preliminary studies, the 
concentration of BSA was fixed at 2.5 μM while that of the dye was varied from 2.5 to 25 
μM. The interaction studies were carried out at 293, 302 and 309 K.  
The site probe studies were performed using different probes viz., warfarin, ibuprofen and 
digitoxin respectively for site I, II and III by keeping the concentration of both protein and 
the probe constant (each at 2.5 μM) and varying the concentration of the dye from 2.5 to 
25 μM. 
The absorption spectra were recorded by scanning the binary mixture of dye and the 
protein in the wavelength range of 250 to 300 nm.  
The FTIR spectrum of BSA in the absence of CBB was obtained by subtracting the IR 
spectrum of buffer. The FTIR spectrum of BSA in presence of CBB was obtained by 
subtracting the IR spectrum of free CBB in buffer from that of the bound CBB to protein in 
the range of 1500 to 1700 cm
−1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.  Fluorescence spectra of BSA. Concentration of BSA was fixed at 2.5 μM (1) 
and that of CBB was varied in the range of 2.5 to 25 μM (2–11). 
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Results and discussion 
CBB–induced quenching studies of bovine serum albumin 
The fluorescence of SA mainly resides in the emission from the tryptophan, Trp (~ 340 nm) 
and tyrosine, Tyr (~ 315 nm) residues. Fluorescence spectra of BSA were recorded in the 
presence and absence of CBB upon excitation at 296 nm. The fluorescence emission of 
protein was observed to be quenched (around 340 nm) in a concentration dependent 
manner by CBB (Fig. 2). 
Quenching of the intrinsic fluorescence of protein can be used to retrieve information on 
ligand–protein binding. The fluorescence quenching data were analyzed using the Stern–
Volmer equation shown below [15]: 
Eq. 1.  ] [ 1
0 Q K
F
F
SV + =  
where F0 and F are the steady–state fluorescence intensities in the absence and presence 
of the quencher (CBB), respectively; Q is the quencher concentration and KSV is the Stern–
Volmer quenching constant. 
The plot of the fluorescence intensity ratio of BSA in the absence and presence of 
quencher (CBB) as a function of the quencher concentration showed a linear dependence 
(Fig. 3). The values of KSV for BSA–CBB system were calculated from the slope of the 
Stern–Volmer plot and the corresponding values are given in Table 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.   The Stern–Volmer plot for quenching of BSA. 
Tab. 1.   KSV, Kq, binding and thermodynamic parameters of CBB–BSA. 
Temp. 
(K) 
KSV 
(mol
−1) 
K 
(mol
−1) 
n  ΔG
0  
(kJ mol
−1) 
ΔH
0 
(kJ mol
−1) 
ΔS
0 
(J mol
−1K
−1) 
293  5.29 x 10
4  2.81 x 10
4 0.94 −24.96 
302  6.52 x 10
4  4.20 x 10
4 0.96 −26.73 
309  8.74 x 10
4  7.95 x 10
4 0.99 −28.99 
48.0  2.49 x 10
2 
♦ 293 K 
 ▲ 302 K 
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The quenching mechanisms are usually classified as either dynamic quenching or static 
quenching. Dynamic and static quenching can be differentiated by their differing 
dependence on temperature [15]. From the results of Stern–Volmer plots, we noticed that 
the  KSV values increased with rise in temperature indicating the presence of dynamic 
quenching mechanism in the interaction of the protein with CBB. Further, it was also 
noticed that the fluorescence intensity of BSA was decreased in the presence of CBB with 
a slight blue shift of the maximum emission wavelength indicating that the chromophores 
of the protein were placed in a more hydrophobic environment after the addition of CBB. 
The blue shift could also be explained by a preferential quenching of the Trp residues that 
would leave only the Tyr residues to contribute to protein fluorescence. Moreover, we 
observed a concomitant increase in the fluorescence intensity at 401 nm, which is the 
characteristic wavelength of the bound BSA. This phenomenon might be the result of the 
radiationless energy transfer between CBB and BSA. Further, the existence of an 
isoactinic point at 375 nm indicated the presence of bound and unbound CBB at 
equilibrium. 
Determination of binding constant and binding capacity 
CBB induced fluorescence quenching data of BSA was analyzed to obtain the binding 
parameters like binding constant (K) and the number of binding sites (n) from the equation 
shown below [16, 17]: 
Eq. 2.  ] [ log log log
0 Q n K
F
F F
+ = ⎟
⎠
⎞
⎜
⎝
⎛ −
 
Fig. 4 depicts the linear plot of log [(F0−F)/F] versus log [Q] and the corresponding results 
of K and n are given in Table 1. The slope registered in this plot was noticed to be close to 
unity revealing that one ligand molecule bound to a molecule of protein. This means, BSA 
has a single class of binding site for CBB. Hence, we propose that CBB most likely binds 
to the hydrophobic pocket located in subdomain IIA, that is to say, Trp–214 is near or 
within the binding site.  
 
 
 
 
 
 
 
 
 
 
Fig. 4.   The plot of log[(F0−F)/F] versus log[Q] for quenching of BSA by CBB at different 
temperatures. 
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The interacting force between CBB and protein 
There are essentially four different types of interacting forces, viz., hydrogen bonds, 
van der Waals forces, electrostatic forces and hydrophobic interactions, which could play a 
major role in ligand binding to serum albumins. The signs and magnitudes of thermo-
dynamic parameters determine the nature of interacting forces, which are taking part in 
drug–protein interactions [18]. The ΔH
0 and ΔS
0 were calculated using the van’t Hoff’s 
equation shown below [19]: 
Eq. 3. 
R
S
RT
H
K
303 . 2
Δ
303 . 2
Δ
log
0 0
+
−
=  
The values of ΔG
0 for the binding process at different temperatures were calculated using 
the equation shown below and the corresponding results are given in Table 1. 
Eq. 4.  K RT G log 303 . 2 Δ
0 − =  
The negative values of ΔG
0 indicated spontaneity of the binding process. The positive 
values of both ΔH
0 and ΔS
0 observed in CBB–BSA system showed revealed that the 
hydrophobic forces played a major role in the binding process between CBB and BSA [18]. 
Exchange of energy between protein and dye 
The fluorescence quenching of BSA by CBB revealed the occurrence of energy transfer 
between the protein and dye. According to the Förster’s non–radiative energy transfer 
theory [15, 20], the energy transfer between protein and dye depends on (a) the overlap of 
the fluorescence emission spectrum of the donor with UV–vis absorption spectrum of the 
acceptor and (b) the distance of approach between the donor and acceptor. The efficiency, 
E of a FRET process depends on the inverse sixth–distance between donor and acceptor 
(r) as well as on the critical energy transfer distance or Förster radius (R0) under the 
condition of 1:1 situation of donor to acceptor concentrations and can be expressed by the 
following equation: 
Eq. 5. 
6 6
0
6
0
0
1
r R
R
F
F
E
+
= − =  
where E is the efficiency of energy transfer; F and F0 are the fluorescence intensities of the 
donor in the presence and absence of the acceptor, respectively. The critical distance, R0 
when the transfer efficiency is 50% can be calculated using the equation: 
Eq. 6.  J N k R
4 2 25 6
0 Φ 10 8 . 8
− − × =  
where k
2 is the spatial orientation factor of the dipole, Ф is the fluorescence quantum yield 
of the donor, N is the refractive index of the medium and J is the overlap integral of the 
fluorescence emission spectrum of the donor and the absorption spectrum of the acceptor.  
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Eq. 7. 
()( )
()() λ ε λ F
λ λ λ ε λ F
J
∑
∑
=
Δ
4
 
where F(λ) is the fluorescence intensity of the donor at wavelength λ and ε(λ) is the molar 
absorptivity of the acceptor at wavelength λ. 
Fig. 5 depicts the overlap between the fluorescence emission spectrum of free protein and 
the absorption spectrum of dye. The efficiency of energy transfer and overlapping 
integration values were obtained from equations 5 and 7, respectively. In order to evaluate 
the Förster’s critical distance using equation 6, we have used k
2 = 2/3; Ф = 0.15; N =1.36 
for BSA [21, 22]. By using the equations 5–7, we have calculated the values of E, r, R0 and 
J and these values were found to be 0.28 nm, 1.9 nm, 1.63 nm and 7.15 x 10
−16 cm
3 m
−1 
for BSA-CBB system. In the present study, r is considered as the average value between 
the bound ligand and two tryptophan residues (Trp–135 and Trp–214) [23]. The value of r 
less than 7 nm indicated the non–radiative energy transfer between BSA and CBB [15].  
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.   The overlap of BSA fluorescence spectrum (1) and CBB absorption spectrum 
(2). [BSA] : [CBB] = 1 : 1. 
Effect of CBB on the Conformation of protein 
Synchronous fluorescence measurements 
Synchronous fluorescence measurements were carried out in order to get the information 
on the molecular environment in the vicinity of the fluorophores (Tyr and Trp) of protein. 
Synchronous fluorescence spectra of BSA (Fig. 6) were obtained by simultaneously 
scanning the excitation and emission monochromater maintaing Δλ =  1 5  n m  ( T y r  
excitation) and Δλ = 60 nm (Trp excitation) between them. Fig. 6 shows the effect of CBB 
on the synchronous spectrum of protein when Δλ = 15 nm (Fig. 6a) or Δλ = 60 nm (Fig. 
6b). As it is evident, the intensity of the tryptophan and tyrosine decreased in the presence 
of CBB; but no significant shift was noticed in the signals. This supported the preferential 
quenching of Trp residues over Tyr residues. This indicated that the binding between CBB 
and the protein did not lead to a change in the polarity of the microenvironment of the 
tryptophan and tyrosine residues, however, the internal packing of the protein changed.  
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Fig. 6.   Synchronous fluorescence spectra of BSA: (a) Δλ = 15 nm; (b) Δλ = 60 nm. 
CBSA = 2.5 μM (1), CCBB = 2.5, 5.0, 7.5, 10.0, 12.5, 15.0, 17.5, 20.0 and 22.5 μM 
(2–10). 
UV–visible absorption measurements 
We have recorded the absorption spectra of BSA in the absence and presence of CBB 
(Figure not shown). The absorption peaks observed around 280 nm were noticed to be 
shifted to the lower wavelength with increase in the concentration of CBB indicating the 
extension of the peptide strands of protein molecules [24, 25].  
FTIR measurements 
FTIR spectroscopy is a well defined tool for the determination of protein’s secondary 
structure [26, 27]. The conformational sensitivity of amide bands is governed by the two 
most important factors viz., hydrogen bonding and the coupling between the transition 
dipoles. Both the amide I (noticed around 1653 cm
−1 due to C=O stretching) and amide II 
bands (observed around 1548 cm
−1 due to C–N stretch coupled with N–H bending mode) 
of the protein have the relationship with secondary structure of protein [28]. It is evident 
from Fig. 8a and Fig. 8b that the secondary structure of BSA was changed. The amide I 
band was noticed to be shifted from 1650.8 cm
−1 (in free BSA) to 1646.9 cm
−1 (in CBB–
BSA) while amide II band was shifted from 1548.1 cm
−1 (in free BSA) to 1554.6 cm
−1(in 
CBB–BSA complex). 
Location of binding site 
The principal regions of the ligand binding sites of albumin are located in the hydrophobic 
cavities of subdomain IIA and IIIA. Sudlow et al [29,  30] have suggested two distinct 
binding sites (site I and site II) in SAs. Warfarin, phenyl butazone etc., have high affinity 
towards site I while ibuprofen, flufenamic acid etc., exhibit affinity towards site II. Zhang et 
al [31] have suggested another site (site III) that has the affinity for digitoxin. In order to 
locate the binding site in BSA, we have recorded the fluorescence intensity of CBB–BSA in 
the presence and absence of site probe and in turn calculated the values of binding 
constant. The corresponding values are given in Table 2. It is clear from Table 2 that there 
is a significant decrease in the binding constant of CBB–BSA in presence of warfarin. 
However, the binding constant values remained almost same in presence of ibuprofen and 
digitoxin. These results revealed that the site I was the main binding site for CBB on 
0
20
40
60
80
100
120
140
260 285 310 335
Wavelength, nm
I
n
t
e
n
s
i
t
y
0
20
40
60
80
100
120
140
300 325 350 375
Wavelength, nm
I
n
t
e
n
s
i
t
y
a b 1 
10 
1 
10   Interaction of Bioactive Coomassie Brilliant Blue G with Protein: Insights from Spectroscopic …  877 
Sci Pharm. 2010; 78: 869–880. 
protein. Therefore, the site I located in the hydrophobic pocket of subdomain IIA was 
proposed to be the binding site for CBB in protein. 
Tab. 2.   The comparison of binding constants of CBB-BSA before and after the addition 
of site probes. 
  K without the  
site probe (mol
−1) 
K with warfarin 
(mol
−1) 
K with ibuprofen 
(mol
−1) 
K with digitoxin
(mol
−1) 
BSA  4.20 x 10
4  7.73 x 10
3  4.22 x 10
4  4.19 x 10
4 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8.   FTIR spectra and difference spectra of BSA: (a) free BSA (subtracting the 
absorption of the buffer solution from the spectrum of the protein solution) and 
(b) the difference spectra of BSA (subtracting the absorption of the CBB–free 
form from that of CBB–BSA bound form); CBSA = CCBB = 2.5 μM. 
Conclusions 
In this paper, the interaction between coomassie brilliant blue G and bovine serum albumin 
was investigated for the first time by fluorescence spectroscopy, UV–visible absorption 
and FTIR spectroscopy under simulative physiological conditions. The fluorescence data 
indicated the strong interaction as characterized by binding constant value of   
4.20 x 10
4 M
−1 at 302 K. Further, the fluorescence quenching mechanism was observed to 
be dynamic process. Hydrophobic force played the major force in the interaction process.  
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